News Image

GILEAD SCIENCES (NASDAQ: GILD) Breakout Swing Trading Idea

By Kristoff De Turck

Last update: Aug 16, 2022

TRADING IDEA (Momentum Swing Trading Breakout)

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. Read the full profile here.

STRATEGY

Breakout Swing Trading Idea

  1. clean breakout during last trading session, wide range bullish bar closed near the high of day (+5.2%)
  2. strongly increased buying volume
  3. closing price above current daily resistance level
  4. long term trend (weekly chart), price breakout above sideways trading channel

Last earnings: 2022-08-02

Next earnings: 2022-10-26



ACTUAL SETUP

  • Buy Stop | $66.36
  • Limit | $66.50
  • Stoploss | $63.44
  • Target | first and second target area on weekly chart

ADDITIONAL INFO/TIPS

Disclaimer: These trading ideas are merely to demonstrate what ChartMill is capable of and shows some typical results of a breakout filter. It is in no way actual financial advise to invest or trade in these stocks. The author has no pre-existing position in any of these stocks.

Back

GILEAD SCIENCES INC

NASDAQ:GILD (4/19/2024, 7:00:00 PM)

After market: 66.76 0 (0%)

66.76

+0.6 (+0.91%)

GILD News

News Image3 days ago - Zacks Investment ResearchGilead Sciences (GILD) Increases Despite Market Slip: Here's What You Need to Know

Gilead Sciences (GILD) closed the most recent trading day at $66.76, moving +0.91% from the previous trading session.

News Image3 days ago - Market News VideoInteresting GILD Put And Call Options For July 19th
News Image4 days ago - Zacks Investment ResearchGilead Sciences (GILD) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Gilead Sciences (GILD) closed at $66.16 in the latest trading session, marking a -1.15% move from the prior day.

News Image4 days ago - Zacks Investment ResearchAnalysts Estimate Gilead Sciences (GILD) to Report a Decline in Earnings: What to Look Out for

Gilead (GILD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

News Image5 days ago - ChartmillWhy the dividend investor may take a look at NASDAQ:GILD.

Uncovering Dividend Opportunities with GILEAD SCIENCES INC (NASDAQ:GILD).

News Image7 days ago - Market News VideoKKR Moves Up In Market Cap Rank, Passing Gilead Sciences
News Image7 days ago - The Motley FoolBetter Growth Play: Merck or The Vanguard Growth Index Fund?

Merck's shares are trading in bargain territory. Are they a better growth play than this popular Vanguard fund?

News Image7 days ago - The Motley FoolShould You Buy the 3 Highest-Paying Dividend Stocks in the Nasdaq?

Dividend stocks can be a smart way to ride out market volatility.

News Image11 days ago - Market News VideoGILD May 31st Options Begin Trading
News Image11 days ago - FinancialNewsMediaBiotech Innovations Paving the Way in Breast Cancer Fight

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GILD),(NASDAQ:GTHX),(NASDAQ:AZN),(NASDAQ:HOLX) EQNX::TICKER_END

News Image11 days ago - USA News GroupBiotech Innovations Paving the Way in Breast Cancer Fight

/PRNewswire/ -- USA News Group – The American Cancer Society is projecting 2024 to be the first year ever for the US to have more than 2 million new cases,...

GILD Links
Follow us for more